MYH3 Antibodies

Santa Cruz Biotechnology delivers a wide array of MYH3 Antibodies for research in muscle biology and related fields. MYH3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYH3, or myosin heavy chain 3, plays a crucial role in muscle contraction and is primarily expressed in developing skeletal muscle. MYH3 is essential for proper muscle function and development during embryogenesis and early postnatal growth. Mutations in the MYH3 gene are associated with congenital myopathies, highlighting its significance in both health and disease. Research focused on MYH3 can provide valuable insights into muscle disorders and potential therapeutic targets. Understanding MYH3 expression patterns and interactions helps elucidate developmental processes in skeletal muscle formation. Investigating MYH3 function contributes to knowledge about muscle fiber type specification and muscle regeneration mechanisms. Santa Cruz Biotechnology monoclonal antibodies for MYH3 enable researchers worldwide to advance scientific understanding of muscle development and disease mechanisms.